Month: January 2018
-
Six Things Every Business Should Do Now To Improve Security
Today, we want to speak about certain things and processes you need to do right now to improve the overall security of your company.
-
Report: 19 New Precision Medicines Approved in 2017
A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals.
-
Brain Stimulation Shown to Slow Alzheimer’s Progression
A small-scale study shows an implanted device providing mild electrical stimulation to the brain’s frontal lobe slows the loss of cognitive functions from Alzheimer’s disease.
-
Surprising Health Benefits When You Play Video Games
There are tons of surprising health benefits that apply across the board.
-
Microsoft Providing A.I. for Big Data Cancer Research
Seven research teams are receiving grants to study complex problems in cancer immunotherapy with large-scale data sets, and assistance with machine learning and artificial intelligence provided by Microsoft Corp.
-
What Does Mumbai Death Mean For The Future Of MRI Testing?
In reality, the MRI machine itself is quite safe. Issues only occur when you introduce other metals into the mix.
-
Grants Made to Commercialize Bone, Cancer Research
A program supporting research with commercial potential awarded grants to scientists studying stem cells for bone grafts, treatments for melanoma, and protein therapies for cancer that change gene expression patterns.
-
Energy Dept Grant Funding Poplar Tree Rust Study
A university-government biotechnology lab is studying the genomics of leaf rust, a fungus afflicting poplar trees, an emerging biofuel crop, with the goal of engineering resistance to the pathogen.
-
Sanofi Buys Nano-Antibody Biotech in $4.8B Deal
Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion.
-
Biotech, Pharma Dominate U.S. Academic Patents
In 2016, patents on biotechnology, pharmaceuticals, and medical technologies accounted for 40 percent of all academic patents, with measurement technologies and organic chemistry each getting 7 percent of the total.